Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tradr 2X Long Snps Daily ETF (SNPX)

Tradr 2X Long Snps Daily ETF (SNPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Tradr ETFs (AXS)
  • Assets Under Management 0
  • Shares Outstanding, K 1,390
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 1.30%

Options Overview Details

View History
  • Implied Volatility 93.96% (-1.20%)
  • Historical Volatility N/A
  • IV Percentile 11%
  • IV Rank 0.00%
  • IV High 105.91% on 11/25/25
  • IV Low 93.96% on 12/08/25
  • Expected Move (DTE 10) 2.98 (8.83%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 71
  • Open Int (30-Day) 28
  • Expected Range 30.71 to 36.66

Most Recent Stories

More News
Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

Newly listed options deliver another tool for traders to express their views on BE, CLS, NNE & SNPS

BEX : 16.81 (-12.45%)
SNPX : 33.68 (-0.30%)
NNEX : 22.83 (+0.51%)
CSEX : 24.35 (+10.98%)
Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

Four funds represent first-to-market strategies offering 200% exposure on trending growth stocks

BEX : 16.81 (-12.45%)
SNPX : 33.68 (-0.30%)
NNEX : 22.83 (+0.51%)
CSEX : 24.35 (+10.98%)
Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for...

SNPX : 33.68 (-0.30%)
Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 33.68 (-0.30%)
Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 33.68 (-0.30%)
Pre-Market Brief: Stocks Mixed As Recession, Rate Hike Fears Persist

March S&P 500 futures (ESH23) are trending up +0.39% this morning after three major U.S. benchmark indices slid for a third successive session and suffered a second consecutive week of losses on Friday...

TSLA : 439.58 (-3.39%)
HEXO : 0.7100 (+2.45%)
SNPX : 33.68 (-0.30%)
CTLT : 63.48 (unch)
ESH23 : 3,957.05s (-0.09%)
ARDX : 5.88 (-1.67%)
Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 33.68 (-0.30%)
Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 33.68 (-0.30%)
Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...

SNPX : 33.68 (-0.30%)
Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...

SNPX : 33.68 (-0.30%)

Fund Summary

The Tradr 2X Long SNPS Daily ETF seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Synopsys, Inc. (NASDAQ: SNPS). The Fund does not seek to achieve its stated investment objective for a period of time different...

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 35.04
2nd Resistance Point 34.49
1st Resistance Point 34.08
Last Price 33.68
1st Support Level 33.12
2nd Support Level 32.57
3rd Support Level 32.16

See More

52-Week High 34.44
Last Price 33.68
Fibonacci 61.8% 29.84
Fibonacci 50% 28.42
Fibonacci 38.2% 27.00
52-Week Low 22.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar